A new gene therapy that successfully treated a rare eye disease in clinical trials could prove the key to preventing more common inherited causes of blindness, researchers say. In six male patients, doctors used a virus to repair a ...
The U.S. Food and Drug Administration today approved the first gel sealant for use in stopping fluid from leaking through the incision in a patient's cornea after cataract surgery with intraocular lens placement in adults. Prior to today's ...
Tags: Gel for Sealing Corneal Incision, First Gel After Cataract Surgery
Less than half of adults who are losing their vision to diabetes have been told by a doctor that diabetes could damage their eyesight, a new study found. Vision loss is a common complication of diabetes, and is caused by damage that the ...
Bayer HealthCare has submitted VEGF Trap-Eye (aflibercept solution for injection) for regulatory approval in Japan to treat patients with myopic choroidal neovascularization (myopic CNV), one of the most common causes of eye disease. In ...
Vycor Medical (Vycor), a medical device company with a suite of FDA cleared products, announced the first release of its new "direct to the patient" saccadic eye training program to be marketed as NeuroEyeCoach. The company further ...
Tags: Vycor, NeuroEyeCoach, saccadic, release
US-based medical device company Vycor Medical has announced the issuance of a new patent in Australia for its NovaVision vision restoration technology. The new Australian patent is for visual testing methods that fixate the user's gaze ...
Tags: Vycor Medical, medical device
Lundbeck, a Denmark-based pharmaceutical company, has obtained the US Food and Drug Administration (FDA) approval for its SABRIL (vigabatrin), an adjunctive treatment option for children 10 and older with refractory complex partial ...
A multiple-sclerosis drug that was at the center of Sanofi SA's SAN.FR +1.12% $20 billion takeover battle for Genzyme Corp. three years ago was approved for sale in Europe on Tuesday, the drug's first regulatory approval world-wide. The ...
The European Commission has approved Regeneron Pharmaceuticals's Eylea (aflibercept) injection for the treatment of visual impairment caused by macular edema secondary to central retinal vein occlusion (CRVO). Eylea is a recombinant ...
Tags: fusion protein, Eylea
Biomedical engineers from The Johns Hopkins University have partnered with clinicians to create new therapeutic eye injections for a type of central vision loss caused by blood vessel growth at the back of the eye. The new drug, with a ...
The National Institute for Health and Clinical Excellence (NICE) in the UK, has recommended Novartis' Lucentis (ranibizumab) be approved for use in the National Health Service (NHS) in England and Wales. Ranibizumab is used to treat ...
For the millions of Americans with vision loss looking for a simple, convenient way to take notes at work, at school, or at home, the American Foundation for the Blind (AFB) today launched the AccessNote, a specialized notetaker for the ...
Tags: AFB, AccessNote, notetaker
One likely effect of the growing number of young people with type 2 diabetes is that more and more people in their 20s and 30s are developing serious eye problems not correctable with glasses. "We've all been aware that obesity and ...
Tags: diabetes, eye problems, eye health, eye diseases
Diagnos has initiated a new screening program for the prevention of diabetic retinopathy and vision loss in Canada. Under the new 'BEAT IT IN A BLINK' program, the company will make use of its proprietary Computer Assisted Retinal ...
Tags: Diagnos, screening program, diabetic retinopathy, vision loss
An environment group has cautioned the public against the improper disposal of compact fluorescent lamps as these energy efficient lighting facilities can be highly toxic due to its mercury content and therefore hazardous to health and ...
Tags: CFL